Location History:
- Colts Neck, NJ (US) (2013 - 2015)
- Hawthorne, NJ (US) (2016 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: The Innovator Behind Breakthrough Medical Discoveries: Ellen K Vande Bunte
Introduction
Ellen K Vande Bunte, based in Colts Neck, NJ, has made significant strides in the field of medicine through her innovative inventions. With a total of five patents to her name, she has focused her research on developing compounds that offer new treatments for various medical conditions. Her contributions to science and healthcare are noteworthy, showcasing her commitment to advancing medical knowledge and therapeutic options.
Latest Patents
Ellen's latest patents highlight her expertise in pharmacology and therapeutic compositions. One of her most prominent inventions includes Factor XIa inhibitors, which provide a compound formula aimed at treating or preventing thromboses, embolisms, hypercoagulability, or fibrotic changes. This invention represents a potential breakthrough in addressing serious health issues related to blood clotting.
Another significant patent involves Mineralocorticoid receptor antagonists. This invention includes compounds and their pharmaceutically acceptable salts that are particularly beneficial for treating aldosterone-mediated diseases. The patent also encompasses processes for preparing these compounds, their therapeutic applications, and pharmaceutical compositions that utilize these innovative compounds.
Career Highlights
Ellen K Vande Bunte’s career is marked by her role at Merck Sharp & Dohme Corporation, a leading pharmaceutical company. During her tenure, she has collaborated with fellow researchers to drive forward the development of critical medical therapies. Her work is reflective of her expertise and the impact that innovative thinking can have on patient care.
Collaborations
Throughout her career, Ellen has partnered with talented colleagues, including Anthony K Ogawa and Rudrajit Mal. These collaborations have led to the creation of groundbreaking inventions that advance the field of medicine and improve patient outcomes. Working alongside such esteemed professionals has amplified her impact within the industry.
Conclusion
Ellen K Vande Bunte is a distinguished inventor whose work continues to influence the medical landscape. Her patents on Factor XIa inhibitors and Mineralocorticoid receptor antagonists are testament to her ingenuity and dedication to improving health care solutions. As she continues to push the boundaries of pharmaceutical innovation, Ellen’s contributions will undoubtedly pave the way for future advancements in medicine.